Mobile CHESS Research on Emergency Medical Services for Children



Status:Completed
Conditions:Asthma, Asthma, Hospital
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:12 - 18
Updated:4/21/2016
Start Date:June 2008
End Date:January 2012

Use our guide to learn which trials are right for you!

The primary aims are to test whether an asthma care management system (M-CHESS) delivered
via a smartphone (cellular phone with internet access) can support low income teenagers
(ages 12-18) with significant asthma and can improve asthma control and reduce
asthma-related emergency or urgent care visits and hospitalizations. Secondary aims include
whether M-CHESS increases adherence to asthma control medication and reduces absenteeism
from school, work or an event they wanted to attend.

Four hundred Milwaukee Medicaid recipients (ages 12-18), with an asthma-related emergency
care visit or hospitalization in the last twelve months, will be recruited through their
managed care organization (MCO). They will be randomly assigned to one of two study arms and
will participate in a 12-month intervention plus a 12-month follow-up period. Subjects in
the control group will receive a smartphone with internet access & text messaging service.
These devices will provide the ability to collect smartphone use data electronically. The
experimental group will also receive the same smartphone devices (with internet access and
text messaging service and ability to collect usedata. In addition the experimental group
will have access to the Mobile CHESS (M-CHESS) interface. The M-CHESS smartphone interface
features an interactive, internet based asthma education program, peer support mechanisms
and automated reminders for asthma control medicines and data collection.

Inclusion Criteria:

- Adolescents ranging in age from 12-18:

- These study candidates will have had an asthma related emergency care visit or
hospitalization in the last 12 months and fit the following characteristics: an
ICD-9 code 493.XX and have filled one or more prescription(s) for an asthma
medication (short acting beta agonist, oral corticosteroid, inhaled or nebulized
corticosteroid, long-acting beta agonist, xanthine, or leukotriene modifier).

- They also must receive medical care from one of the two participating managed
care organizations involved in our study.

Exclusion Criteria:

- Other chronic pulmonary disorders such as cystic fibrosis, ABPA, or bronchopulmonary
dysplasia.

- Developmental/cognitive/sensory disabilities.
We found this trial at
2
sites
Milwaukee, Wisconsin 53214
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Milwaukee, Wisconsin 53226
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials